Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date How scholarly literature can support Medical Science Liaisons Dr. Nadège Krebs Medical Affairs specialists facilitate the flow of unbiased information from science to pharma as medical science liaisons. This efficient exchange be... 2 years ago | 43 mins Applying behavioural interventions in chronic diseases Cara Blair, Robert Poole, Ian Greenway, Pippa Colden, Complete HealthVizion, Dominic Tyer, pharmaphorum Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on patients’ lives and the provision of healthca... 2 years ago | 62 mins Targeting IDH mutations in Cancer Brandon Nicolay, PhD, Associate Director, Pharmacology, Agios Pharmaceuticals Somatic mutations in the enzyme isocitrate dehydrogenase 1 (IDH1) arise in roughly 6–10% of patients with acute myeloid leukemia (AML). These mutation... 2 years ago | 34 mins Models for evaluating cancerous stem cell-targeting therapeutics Lynn Biderman, PhD, Senior Scientist, Stelexis Therapeutics Cancer formation and progression are largely driven by cancerous stem cells (CSCs). CSCs are typically not eliminated by conventional treatment approa... 2 years ago | 34 mins Digital health: how can technology be used to engage hard-to-reach patients? Trishna Bharadia, MS patient advocate, Jo Sopala, MS Trust, Rachel Morrison, NHS Western Isles Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are asked to manage multiple physical and ps... 4 years ago | 65 mins Rare Oncology Research in the 21st Century Sachin Kulkarni and Juliet M. Moritz Study of rare cancers tends to look more like rare disease research than standard oncology research. This webinar will highlight some of the challenge... 2 years ago | 61 mins IP and R&D Trends in Biological Sequencing Karthik Subramanian (PatSnap), Shivshankar Umashankar (PatSnap), and Tom Phillips (WIPR) A recent study from McKinsey claims that 45% of the world’s disease burden could be addressed by biological means. With the increasing number of cance... 2 years ago | 39 mins Challenges and Risks in Development and Manufacture of Covid 19 Vaccines Rajesh K. Gupta, Ph.D. Biologics Quality & Regulatory Consultants, LLC, North Potomac Coronavirus disease (COVID-19) is a terrifying illness with high morbidity and mortality throughout the world and with devastating effects on business... 2 years ago | 121 mins Strengthening Neuroscience Clinical Research Through Innovation Juliet Moritz and Barry Dussault There’s a lot of discussions these days about innovative ideas to make clinical research more patient-focused. The concept goes hand-in-hand with the ... 2 years ago | 63 mins Russia: The Inside Story Lucia Railean, Cegedim CIS Vsevolod Tyupa, CMS Cameron McKenna, Russia This free programme will provide first hand insights into the opportunities and challenges which face pharmaceutical companies who want to enter or de... 11 years ago | 62 mins
